
About 85% of all instances of lung cancer are non-small cell lung cancer (NSCLC), making it the most common kind of the disease. It happens when aberrant cells proliferate in the lungs and cause tumors to grow. Compared to small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC) is typically less aggressive and grows and spreads more slowly.
Type of Non-Small Cell Lung Cancer (NSCLC)
There are many types of NSCLC, including-
What is the Importance of Timely Treatment?
Timely treatment of Non-Small Cell Lung Cancer (NSCLC) is essential for several reasons:
Respiratory Symptoms
Chest Symptoms
General Symptoms
Causes
Risk Factors
India's increasing proficiency in precision medicine, immunotherapy, targeted medicines, and minimally invasive surgery has enhanced NSCLC diagnosis and treatment.
A novel approach to treating cancer is chimeric antigen receptor T-cell (CAR-T) therapy, which entails modifying T cells to have receptors intended to recognise and destroy tumor cells. Researchers are looking into possible targets for CAR-T therapy in NSCLC, such as mesothelin, EGFR, and PD-L1. Early results from preliminary clinical trials assessing the safety and efficacy of CAR-T cells in patients with non-small cell lung cancer are promising.
There are a few things you can do to lower your risk of developing Non-Small Cell Lung Cancer (NSCLC), particularly of the bladder, even if it is not always preventable:
Treatment options for NSCLC differ based on the type and stage of the disease and the patient's overall health. The following are a few current treatments:
Lobectomy: Elimination of a lung lobe. The most popular procedure for NSCLC in its early stages is this one.
Pneumonectomy: Removal of a lung in its whole. If the cancer is in an area of the lung where the entire organ needs to be removed, this procedure might be carried out.
Wedge Resection: This removes a little lung section with the tumor.
Segmentectomy: This is the Removal of a more prominent lung segment but not the entire lobe. Usually, this is applied to individuals with lung impairment or early-stage cancer.
Radiation Therapy: Treatments using high-energy rays to target cancer cells and reduce tumour size are known as radiation therapy. It may be used in combination with chemotherapy for Non-Small Cell Lung Cancer (NSCLC).
Targeted Therapy : Medication designed for particular forms of lung cancer is used in this treatment. Targeted therapy can locate and target specific cancer cells without endangering healthy cells.
Cost Start From USD 8000 - USD 12000Explore Options
Immunotherapy : This is typically advised for late-stage lung cancer, notably Stage IV NSCLC, as it triggers your body's immune system to target and eliminate cancer cells.
Cost Start From USD 3000 - USD 5000Explore Options
Chemotherapy : It uses medications that target lung cancer. It is among the most widely used therapies for NSCLC. Chemotherapy may be prescribed by your oncologist alone or in conjunction with other treatments.
Cost Start From USD 600 - USD 700Explore Options
Clinical Evaluation
Imaging Studies
Biopsy
Laboratory Tests
MediRehab (chain of Rehab centres - Part of MediGence) provides comprehensive rehabilitation services designed to support NSCLC patients in India. These services include:
Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.









Delhi, India
Clear Medi Hospital, Karkardooma located in New Delhi, India is accredited by ISO. Also listed below are some of the most prominent infrastructural details:

Hyderabad, India
American Oncology Institute located in Hyderabad, India is accredited by AAAHC. Also listed below are some of the most prominent infrastructural details:

Chennai, India
MIOT started its journey with only 70 beds and focusing on Orthopedics and Trauma care. However, we grew into a multi-specialty hospital with time. MIOT is now a 1000-bedded hospital and can offer an extensive range of services across 63 specialties. The state of art laboratory of our hospital is ranked 8th internationally. We have 21 super-specialty operation theaters equipped with cutting-edge technology to help our doctors with complex procedures.
We take great care to make our patient rooms comfortable enough. The patient rooms get plenty of fresh air as well as natural light. The soothing views from the rooms do not let the patients feel cut off from the outside world. We use separate entrances for emergency patients, out-patients, in-patients, and their attendants. We put our patients’ safety first which is why we use a superior air system to ensure a near-zero infection healthy environment.
Apart from that, MIOT’s 24 hours blood bank provides all kinds of blood work related services which include blood collection to component separation. This state-of-art blood bank alone handles more than 30,000 units of blood over the course of a year. Every month around 600 blood transfusions are managed by this blood bank.
MIOT’s SIGNA Pioneer 3T MRI machine is made with noise reduction technology. This silent MRI machine can deliver superior quality neuroimages without wasting any time. The department of Radiology and Imaging Sciences can give tough competition to any international hospital with its advanced technology and accuracy.
The PET CT service at MIOT International is the first of its kind in South India enabling better and more accurate diagnosis than earlier. The superior diagnosis is also possible for the two digital cath labs at MIOT Heart Revive center.
We also have a physiotherapy team where a team of highly efficient physiotherapists deals with the mobility and functional disability issues of our patients. They listen to the patients carefully to identify the root of the pain and use therapeutic exercises to reduce their pain.
The CCU of MIOT is something to be proud of. The specially-trained staff of this unit is dedicated to ensuring top-quality medical support to serious patients. This unit along with the MIOT International Laboratory is the backbone of our facility.
Furthermore, what makes MIOT unique is our Telemedicine service. In the new normal, we are trying everything to reach our patients. Our one of its kind Telemedicine service connects our patients to our 250 full-time doctors over email, phone, chat and video consultations.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Depending on the cancer's stage and treatment strategy, NSCLC therapy success rates in India vary. The 5-year survival rate for early-stage non-small cell lung cancer (NSCLC) can reach 60% to 70% if the disease is identified early and treated surgically.
The type of treatment received determines how long it takes to recover from NSCLC in India. Patients usually spend five to seven days in the hospital following lung surgery, and it may take them two to three months to fully recover. Fatigue is one of the side effects of radiation and chemotherapy, and it sometimes takes patients one to two months to recover their strength.
In India, it is customary practice to get a second opinion. In India, a lot of hospitals and oncologists are willing to assess cases and offer second opinions on treatment strategies. One can:
Yes, MediGence offers a wide range of assistance to patients from other countries seeking treatment for non-small cell lung cancer. The majority of large hospitals offer specialised departments for international patients that help with accommodations, airport transfers, visa arrangements, and language translation. To ensure that overseas patients have a seamless and hassle-free experience throughout their treatment journey, these departments also assist with financial information, appointment scheduling, and post-treatment care.
For NSCLC patients in India, post-treatment care and follow-up options include routine imaging tests (such as CT or PET scans) to look for recurrence and blood tests to assess general health.
To enhance endurance and recover lung function, particularly following surgery or radiation therapy, patients also undertake pulmonary rehabilitation.
While psychological assistance and counseling are given to help deal with the emotional difficulties of cancer treatment, nutritional advice is offered to help manage weight and recovery.
The patient's general health, the stage of the cancer at diagnosis, and the efficacy of the treatment all affect the prognosis. Advanced treatment options and early discovery can increase survival rates.
Yes, even after a successful course of treatment, non-small cell lung cancer (NSCLC) might return. The type of treatment received, the patient's response to the treatment, and the stage of the cancer at diagnosis all affect the chance of recurrence.
Yes, NSCLC is among the most common forms of lung cancer in India, although it is still less common than other malignancies like colorectal or breast cancer. Overall, lung cancer is one of the most common cancers in India, with 80–85% of cases being NSCLC

Medical Oncologist
14 Years of Experience
One of the finest Oncologist in New Delhi, India, Dr. Mohit Agarwal has worked with several world class multidisciplinary hospitals over the years. Dr. Mohit Agarwal has over 14+ years of experience in his field. The doctor treats and manages a wide range of conditions such as Stomach Cancer, Rectal Cancer, Breast Cancer, Brain Cancer View More
Last Reviewed - January 2026